Association of baseline big endothelin-1 level with long-term prognosis among cardiac resynchronization therapy recipients.
CONCLUSION: Baseline big ET-1 > 0.56 pmol/L was independently associated with higher all-cause mortality and HFH among CRT recipients, and therefore can be added to the marker panel used for stratifying high risk CRT patients for priority treatment.
PMID: 29913121 [PubMed - as supplied by publisher]
Source: Clinical Biochemistry - Category: Biochemistry Authors: Yang S, Liu Z, Liu S, Ding L, Chen K, Hua W, Zhang S Tags: Clin Biochem Source Type: research
More News: Biochemistry | Cardiac Resynchronization Therapy | Cardiology | Heart | Heart Failure | Heart Transplant | Transplants